FXAIX
Price
$265.83
Change
-$2.30 (-0.86%)
Updated
Aug 20 closing price
Net Assets
833.14B
VCGAX
Price
$38.38
Change
-$0.36 (-0.93%)
Updated
Aug 20 closing price
Net Assets
675.06M
Interact to see
Advertisement

FXAIX vs VCGAX

FXAIX vs VCGAX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. VCGAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a StrongBuy and VCGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 833B vs. VCGAX (675M). FXAIX pays higher dividends than VCGAX: FXAIX (1.06) vs VCGAX (0.62). FXAIX was incepted earlier than VCGAX: FXAIX (15 years) vs VCGAX (32 years). VCGAX (0.86) is less costly to investors than FXAIX (0.01). VCGAX is a more actively managed with annual turnover of: 36.00 vs. FXAIX (3.00). FXAIX (0) and VCGAX (0) have matching initial minimum investment requirements. FXAIX annual gain was more profitable for investors over the last year : 21.35 vs. VCGAX (10.87). FXAIX return over 5 years is better than : 84.67 vs. VCGAX (42.96).
FXAIXVCGAXFXAIX / VCGAX
Total Expense Ratio0.010.642%
Annual Report Gross Expense Ratio0.010.862%
Fund Existence15 years32 years-
Gain YTD12.4373.870321%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets833B675M123,407%
Annual Yield % from dividends1.060.62171%
Returns for 1 year21.3510.87196%
Returns for 3 years81.1552.77154%
Returns for 5 years84.6742.96197%
Returns for 10 years286.57117.64244%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIGIX39.040.46
+1.19%
JHancock International Growth R4
GQSIX19.900.20
+1.02%
Glenmede Disciplined U.S. Sm Cp Eq Instl
WFEIX65.330.49
+0.76%
Allspring Mid Cap Growth Fund - Cl Inst
RYVLX842.175.14
+0.61%
Rydex NASDAQ-100® 2x Strategy A
AIGGX15.930.05
+0.31%
Aristotle Growth Equity I-2